Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci Sells 339 Shares

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 339 shares of the business’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $40.23, for a total transaction of $13,637.97. Following the transaction, the chief accounting officer now directly owns 71,007 shares in the company, valued at approximately $2,856,611.61. The trade was a 0.48 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Tempus AI Stock Down 12.0 %

Shares of NASDAQ:TEM opened at $34.29 on Thursday. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $79.49. The company has a 50 day moving average price of $52.24. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on TEM shares. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their target price for the company from $45.00 to $65.00 in a report on Monday, November 11th. Loop Capital lifted their price target on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Guggenheim assumed coverage on Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 price objective for the company. Wolfe Research assumed coverage on Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price on the stock. Finally, Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

Institutional Investors Weigh In On Tempus AI

A number of hedge funds and other institutional investors have recently modified their holdings of TEM. Kovitz Investment Group Partners LLC acquired a new position in Tempus AI in the third quarter valued at $1,367,000. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Tempus AI by 1,591.2% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock valued at $68,922,000 after purchasing an additional 1,145,698 shares during the last quarter. Captrust Financial Advisors acquired a new stake in shares of Tempus AI in the 3rd quarter valued at about $2,726,000. Sigma Planning Corp acquired a new stake in shares of Tempus AI in the 3rd quarter valued at about $1,323,000. Finally, Dakota Wealth Management purchased a new position in Tempus AI during the 3rd quarter worth approximately $1,185,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.